The majority of TAMs are of the M2 phenotype (marked by CD163), with rare M1 HLA‐DR‐stained cells.[321] EGFR‐activated NSCLC tumors promote ILT4 expression via the EGFR‐AKT and ERK1/2 signaling. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.